NCT05965570View on ClinicalTrials.gov

A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 28, 2023

Primary Completion Date

September 22, 2023

Study Completion Date

September 22, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

Brensocatib

Oral tablets.

DRUG

Clarithromycin

Oral tablets.

Trial Locations (1)

75247

USA001, Dallas

All Listed Sponsors
lead

Insmed Incorporated

INDUSTRY

NCT05965570 - A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants | Biotech Hunter | Biotech Hunter